Actos Bladder Cancer Plaintiffs Win $8M from California Jury
A woman who lost her husband to bladder cancer has been awarded a total of $8 million in damages by a California jury who, after eight days of deliberation, ruled that Takeda Pharmaceuticals, Inc. (the maker of Actos) failed to properly warn the public about the risk of bladder cancer when taking the diabetes drug Actos. This Actos bladder cancer …
“Plaintiff Was Hypersensitive,” DePuy Lawsuit Defense Witness States
The jury in the second DePuy hip implant lawsuit to go to trial (Carol Strum v. DePuy Orthopaedics, Inc. et al, case no. 2011-L-009352) has recently heard testimony from an expert witness for the defense alleging that: The plaintiff was likely hypersensitive to a normal amount of debris shed from the DePuy ASR XL metal-on-metal hip implant. The device, upon …
DePuy hip implant first jury trial begins in Maryland
Jury selection was scheduled to begin this week in Prince George’s County, Maryland, over claims that Johnson & Johnson failed to warn a former professional dancer and her doctors about risks with two DuPuy ASR™ hip implants she received. Moira Jackson, who says the implants caused “severe physical distress and injury” until she was “unable to lead a normal life,” …
First pelvic mesh injury case begins with jury selection in New Jersey
Jury selection began January 7, 2013, in Atlantic County (N.J.) Superior Court over claims the Gynecare Prolift® Pelvic Floor Repair System caused injuries that forced a patient to endure multiple treatments and surgeries and caused permanent damage. Linda Gross, a South Dakota nurse, claims the Johnson & Johnson pelvic mesh implant was defective in design and manufacture and that the …
Johnson & Johnson settles 845 Levaquin lawsuits in federal court
Court records indicate that Johnson & Johnson, maker of the antibiotic Levaquin, has reached settlements with about 845 of 1,900 plaintiffs in a multidistrict litigation case in U.S. District Court in Minnesota. The initial agreements will be completed soon, though terms of the settlement are confidential, according to a spokesman for the manufacturer based in New Brunswick, N.J. More than …
First Chantix bellwether trial set for January 2013
A lawsuit filed by an Alabama man against Pfizer Inc., maker of the anti-smoking drug Chantix, has been designated the bellwether (test case) among more than 2,600 federal lawsuits filed nationwide. The trial is set to begin Jan. 22 in Florence, Alabama, before U.S. District Court Judge Inge Johnson. Billy G. Bedsole Jr.’s lawsuit became the bellwether after the manufacturer …
